These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29368282)

  • 1. Suboptimal lipid management before and after ischaemic stroke and TIA-the North Dublin Population Stroke Study.
    Ní Chróinín D; Ní Chróinín C; Akijian L; Callaly EL; Hannon N; Kelly L; Marnane M; Merwick Á; Sheehan Ó; Horgan G; Duggan J; Kyne L; Dolan E; Murphy S; Williams D; Kelly PJ
    Ir J Med Sci; 2018 Aug; 187(3):739-746. PubMed ID: 29368282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
    Mullard AJ; Reeves MJ; Jacobs BS; Kothari RU; Birbeck GL; Maddox K; Stoeckle-Roberts S; Wehner S;
    Stroke; 2006 Jan; 37(1):44-9. PubMed ID: 16339479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid management in ischaemic stroke or transient ischaemic attack in China: result from China National Stroke Registry III.
    Xu YY; Chen WQ; Wang MX; Pan YS; Li ZX; Liu LP; Zhao XQ; Wang YL; Li H; Wang YJ; Meng X;
    BMJ Open; 2023 Mar; 13(3):e069465. PubMed ID: 36889830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the utility of fasting lipid panel in addition to random lipid panel in determining lipid-lowering therapy in acute ischemic stroke or TIA patients.
    Shehzad U; Tumati A; Reinsel RA; Singh D; Dadra D; Purushotham A; Mathew J
    Clin Neurol Neurosurg; 2020 Oct; 197():106068. PubMed ID: 32688096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a locally adapted, secondary stroke risk factor self-management program on medication adherence among veterans with stroke/TIA.
    Damush TM; Myers L; Anderson JA; Yu Z; Ofner S; Nicholas G; Kimmel B; Schmid AA; Kent T; Williams LS
    Transl Behav Med; 2016 Sep; 6(3):457-68. PubMed ID: 27349906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.
    Kitagawa K; Hosomi N; Nagai Y; Kagimura T; Ohtsuki T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Nakamura M; Matsumoto M;
    J Atheroscler Thromb; 2019 May; 26(5):432-441. PubMed ID: 30318492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after transient ischemic attack: the North Dublin TIA study.
    Sheehan OC; Kyne L; Kelly LA; Hannon N; Marnane M; Merwick A; McCormack PM; Duggan J; Moore A; Moroney J; Daly L; Harris D; Horgan G; Williams EB; Kelly PJ
    Stroke; 2010 May; 41(5):844-50. PubMed ID: 20299667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack.
    Yeh PS; Lin HJ; Bai CH; Hsieh FI; Ke DS; Li YH;
    Am J Cardiol; 2010 May; 105(10):1490-4. PubMed ID: 20451701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA.
    Pan Y; Wangqin R; Li H; Jin A; Li J; Lin J; Meng X; Xian Y; Laskowitz DT; Wang Y
    Stroke Vasc Neurol; 2022 Aug; 7(4):276-284. PubMed ID: 35256525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
    Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
    BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC;
    J Hosp Med; 2006 Jul; 1(4):214-20. PubMed ID: 17219502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
    Gynnild MN; Hageman SHJ; Spigset O; Lydersen S; Saltvedt I; Dorresteijn JAN; Visseren FLJ; Ellekjær H
    Open Heart; 2022 Apr; 9(1):. PubMed ID: 35459718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack].
    Palacio E; Viadero-Cervera R; Revilla M; Larrosa-Campo D; Acha-Salazar O; Novo-Robledo F; Oterino A
    Rev Neurol; 2016 Mar; 62(5):203-10. PubMed ID: 26916323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack.
    Lalouschek W; Lang W; Greisenegger S; Müllner M;
    Stroke; 2003 Jan; 34(1):105-10. PubMed ID: 12511759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke Study.
    Akijian L; Ní Chróinín D; Callaly E; Hannon N; Marnane M; Merwick Á; Sheehan Ó; Hayden D; Horgan G; Duggan J; Kyne L; O'Rourke K; Murphy S; Dolan E; Williams D; Kelly PJ
    Int J Stroke; 2017 Jan; 12(1):96-104. PubMed ID: 27698281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
    Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
    Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
    Zanchetti A; Liu L; Mancia G; Parati G; Grassi G; Stramba-Badiale M; Silani V; Bilo G; Corrao G; Zambon A; Scotti L; Zhang X; Wang H; Zhang Y; Zhang X; Guan TR; Berge E; Redon J; Narkiewicz K; Dominiczak A; Nilsson P; Viigimaa M; Laurent S; Agabiti-Rosei E; Wu Z; Zhu D; Rodicio JL; Ruilope LM; Martell-Claros N; Pinto F; Schmieder RE; Burnier M; Banach M; Cifkova R; Farsang C; Konradi A; Lazareva I; Sirenko Y; Dorobantu M; Postadzhiyan A; Accetto R; Jelakovic B; Lovic D; Manolis AJ; Stylianou P; Erdine S; Dicker D; Wei G; Xu C; Xie H; Coca A; O'Brien J; Ford G
    J Hypertens; 2014 Sep; 32(9):1888-97. PubMed ID: 24979303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.